DotBio
- | Biotech or pharma, therapeutic R&D
DotBio is an asset-driven, clinical trial-validated biotech company that has developed an antibody platform for rapid and reliable generation of multi-targeted antibody therapeutics: bi- and tri-specific antibodies, antibody-drug conjugates, and intracellular antibodies against diverse disease targets.
Address
USAUnited States
)
){kind=logo}
)
){kind=logo}
){kind=logo}
){kind=logo}
)
){kind=logo}
)
)
){kind=logo}
){kind=logo}
)
)
){kind=logo}
){kind=logo}
){kind=logo}